Chapman Investment Management LLC Sells 10,479 Shares of GE HealthCare Technologies Inc. $GEHC

Chapman Investment Management LLC trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.8% during the second quarter, Holdings Channel reports. The institutional investor owned 71,677 shares of the company’s stock after selling 10,479 shares during the quarter. GE HealthCare Technologies makes up about 3.7% of Chapman Investment Management LLC’s investment portfolio, making the stock its 12th biggest holding. Chapman Investment Management LLC’s holdings in GE HealthCare Technologies were worth $5,309,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of GEHC. JPMorgan Chase & Co. boosted its position in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after buying an additional 1,711,963 shares during the last quarter. Nuveen LLC bought a new position in GE HealthCare Technologies in the 1st quarter valued at $77,058,000. Eminence Capital LP boosted its position in GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after buying an additional 507,101 shares during the last quarter. Homestead Advisers Corp boosted its position in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after buying an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its position in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after buying an additional 409,636 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on GEHC. Evercore ISI increased their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Citigroup lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. BTIG Research set a $87.00 price target on GE HealthCare Technologies in a research report on Wednesday, October 29th. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $74.47 on Tuesday. The company has a market capitalization of $33.92 billion, a PE ratio of 15.39, a PEG ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The stock’s fifty day simple moving average is $75.09 and its 200 day simple moving average is $73.22.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter last year, the business posted $1.14 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.